Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Oncology
Study Phase : Undisclosed
Recipient : SWOG Cancer Research Network
Deal Size : Inapplicable
Deal Type : Inapplicable
S1916 Digital Medicine Program for Pain Control in Cancer Patients
Details : Oxycodone is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Neoplasms.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
December 11, 2019
Lead Product(s) : Oxycodone Hydrochloride
Therapeutic Area : Oncology
Highest Development Status : Undisclosed
Recipient : SWOG Cancer Research Network
Deal Size : Inapplicable
Deal Type : Inapplicable